[Moving towards a personalized oncology: The contribution of genomic techniques and artificial intelligence in the use of circulating tumor biomarkers].
- DOI
- 10.1016/j.bulcan.2021.12.005
- Published
- 2022-01-13
- Container
- Bull Cancer
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bulcan.2021.12.005,
title = {[Moving towards a personalized oncology: The contribution of genomic techniques and artificial intelligence in the use of circulating tumor biomarkers].},
author = {Perrier A and Hainaut P and Guenoun A and Nguyen DP and Lamy PJ and Guerber F and Troalen F and Denis JA and Boissan M.},
year = {2022},
journal = {Bull Cancer},
doi = {10.1016/j.bulcan.2021.12.005},
url = {https://doi.org/10.1016/j.bulcan.2021.12.005}
}RIS
TY - JOUR TI - [Moving towards a personalized oncology: The contribution of genomic techniques and artificial intelligence in the use of circulating tumor biomarkers]. AU - Perrier A AU - Hainaut P AU - Guenoun A AU - Nguyen DP AU - Lamy PJ AU - Guerber F AU - Troalen F AU - Denis JA AU - Boissan M. PY - 2022 JO - Bull Cancer DO - 10.1016/j.bulcan.2021.12.005 UR - https://doi.org/10.1016/j.bulcan.2021.12.005 ER -
APA
A, P., P, H., A, G., DP, N., PJ, L., F, G., F, T., JA, D., & M., B. (2022). [Moving towards a personalized oncology: The contribution of genomic techniques and artificial intelligence in the use of circulating tumor biomarkers].. Bull Cancer. https://doi.org/10.1016/j.bulcan.2021.12.005
Source records
- europe-pmc · retrieved 2026-09-26T07:19:24.535Z
- hal · retrieved 2026-09-26T07:19:24.551Z